The civic record
Read. Follow. Verify.Utah expands patient access to investigational drugs and medical devices under Right to Try law
Last action · March 18, 2026: Governor SignedSponsors: Chris Wilson and 1 other
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
Utah law now allows eligible patients with severe or life-threatening conditions to obtain s and devices under expanded circumstances, while requiring manufacturers to submit annual safety and usage reports to the Legislature starting May 6, 2026.
Patients facing debilitating illnesses gain wider legal pathways to unapproved medical treatments, while medical manufacturers face a mandatory annual reporting requirement regarding patient outcomes and adverse events.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Eligible patients
Patients diagnosed with severe, debilitating, or terminal conditions gain expanded statutory access to investigational drugs and devices.
Investigational drug and device manufacturers
Manufacturers providing unapproved treatments to Utah residents must compile and submit annual adverse outcome and patient usage data to a legislative committee.
Physicians
Licensed medical and osteopathic physicians are authorized to diagnose qualifying conditions and determine patient eligibility for investigational treatments.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
Who qualifies to receive an investigational drug or device under this law?
What information must manufacturers report to the state?
Are all manufacturers required to submit the annual report?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Current status: Signed into law.
Procedural history
49 actions- Mar 18, 2026Lieutenant Governor's office for filingEnrolledGovernor Signed
- Mar 13, 2026SenateSenate/ to Governor
- Mar 13, 2026SenateSenate/ received enrolled bill from Printing
- Mar 11, 2026SenateSenate/ enrolled bill to Printing
- Mar 11, 2026Senate SecretaryEnrolled Bill Returned to House or Senate
- Mar 6, 2026Legislative Research and General Counsel / EnrollingDraft of Enrolled Bill Prepared
Show 43 earlier actions
- Mar 6, 2026Legislative Research and General Counsel / EnrollingBill Received from Senate for Enrolling
- Mar 6, 2026SenateSenate/ signed by President/ sent for enrolling
- Mar 6, 2026SenateSenate/ received from House
- Mar 5, 2026HouseHouse/ to Senate
- Mar 5, 2026HouseHouse/ signed by Speaker/ returned to Senate
- Mar 5, 2026HouseFloorHouse/ passed 3rd reading
- Mar 5, 2026HouseHouse/ 3rd reading
- Mar 2, 2026HouseHouse/ 2nd reading
- Mar 2, 2026HouseHouse/ committee report favorable
- Feb 27, 2026HouseHouse Comm - Favorable Recommendation
- Feb 25, 2026HouseCommitteeHouse/ to standing committee
- Feb 24, 2026HouseIntroducedHouse/ 1st reading (Introduced)
- Feb 23, 2026HouseHouse/ received from Senate
- Feb 23, 2026SenateSenate/ to House
- Feb 23, 2026SenateFloorSenate/ passed 3rd reading
- Feb 23, 2026SenateSenate/ uncircled
- Feb 23, 2026ReleasedLFA/ fiscal note publicly available for SB0222S02
- Feb 23, 2026Version SponsorLFA/ fiscal note sent to sponsor for SB0222S02
- Feb 23, 2026SenateSenate/ circled
- Feb 23, 2026SenateSenate/ substituted
- Feb 23, 2026SenateSenate/ 3rd reading
- Feb 23, 2026Legislative Fiscal AgencyLFA/ bill sent to agencies for fiscal input for SB0222S02
- Feb 23, 2026Legislative Fiscal AnalystLFA/ bill assigned to staff for fiscal analysis for SB0222S02
- Feb 20, 2026SenateFloorSenate/ passed 2nd reading
- Feb 20, 2026SenateSenate/ substituted
- Feb 20, 2026SenateSenate/ 2nd reading
- Feb 19, 2026ReleasedLFA/ fiscal note publicly available for SB0222S01
- Feb 18, 2026Version SponsorLFA/ fiscal note sent to sponsor for SB0222S01
- Feb 17, 2026Legislative Fiscal AgencyLFA/ bill sent to agencies for fiscal input for SB0222S01
- Feb 17, 2026Legislative Fiscal AnalystLFA/ bill assigned to staff for fiscal analysis for SB0222S01
- Feb 4, 2026SenateSenate/ placed on 2nd Reading Calendar
- Feb 4, 2026SenateSenate/ committee report favorable
- Feb 3, 2026SenateSenate Comm - Favorable Recommendation
- Feb 2, 2026SenateCommitteeSenate/ to standing committee
- Feb 2, 2026SenateSenate/ received fiscal note from Fiscal Analyst
- Feb 2, 2026ReleasedLFA/ fiscal note publicly available for SB0222
- Feb 2, 2026Version SponsorLFA/ fiscal note sent to sponsor for SB0222
- Jan 30, 2026SenateIntroducedSenate/ 1st reading (Introduced)
- Jan 29, 2026SenateSenate/ received bill from Legislative Research
- Jan 29, 2026Legislative Fiscal AgencyLFA/ bill sent to agencies for fiscal input for SB0222
- Jan 29, 2026Legislative Fiscal AnalystLFA/ bill assigned to staff for fiscal analysis for SB0222
- Jan 29, 2026Legislative Research and General CounselNumbered Bill Publicly Distributed
- Jan 29, 2026Legislative Research and General CounselBill Numbered but not Distributed
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Expansion of Right to Try Framework
The state shifts from strictly terminal illness limitations to encompassing broader severely debilitating or life-threatening conditions.
Connected Entities
Sources
le.utah.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy25Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz35Current news / social attention level
Publisher tools